Cytokines in central nervous system: Targets for therapeutic intervention

Current Drug Targets: CNS and Neurological Disorders

Volumn 3, Issue 4, 2004, Pages 271-280

  Safieh Garabedian, Bared ^a   Haddad, John J ^a   Saadé, Nayef E ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

CNS; Cytokines; Drugs; Immune therapy; Inflammation; Neurodegeneration; Pathophysiology

Indexed keywords

4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA INTERMEDIN; APOMORPHINE; BETA INTERFERON; CAPSAICIN; CYTOKINE; DEFEROXAMINE; DEXAMETHASONE; DICLOFENAC; DIZOCILPINE; ERYTHROPOIETIN; GAMMA INTERFERON; GLATIRAMER; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; METHYLPREDNISOLONE; RECOMBINANT ERYTHROPOIETIN; ROLIPRAM; TEPOXALIN; THYMULIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; BRAIN; BRAIN INJURY; CENTRAL NERVOUS SYSTEM DISEASE; DEGENERATIVE DISEASE; DRUG DESIGN; DRUG RESEARCH; DRUG TARGETING; ENZYME INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL; NERVE INJURY; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PROTEIN FUNCTION; REVIEW; SPINAL CORD INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CENTRAL NERVOUS SYSTEM; CYTOKINES; ENCEPHALITIS; HUMANS; IMMUNOTHERAPY; INFLAMMATION MEDIATORS; MICROGLIA; NEURODEGENERATIVE DISEASES;

EID: 4544387742     PISSN: 1568007X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568007043337300     Document Type: Review

References (136)

1. Besedovsky, H.O.; del Rey, A. Endocr. Rev., 1996, 17, 64.
2. Haddad, J.J.; Saadé, N.E.; Safieh-Garabedian, B. J. Neuroimmunol., 2002, 133, 1.
3. John, C.D.; Buckingham, J.C. Curr. Opin. Pharmacol., 2003, 3, 78.
4. Moro, M.A.; Hurtado, O.; Cardenas, A.; Romera, C.; Madrigal, J.L.; Fernandez-Tome, P.; Leza, J.C.; Lorenzo, P.; Lizasoain, I. Neurosignals, 2003, 12, 53.
5. Hermus, A.R.; Sweep, C.G. J. Steroid Biochem. Mol. Biol., 1990, 37, 867.
6. Elenkov, I.J.; Chrousos, G.P. Trends Endocrinol. Metab., 1999, 10, 359.
7. Masek, K.; Slansky, J.; Petrovicky, P.; Hadden, J.W. Int. Immunopharmacol., 2003, 3, 1235.
8. Rothwell, N.J.; Luheshi, G.N. Trends Neurosci., 2000, 23, 618.
9. Hosoi, T.; Okuma, Y.; Nomura, Y. Curr. Drug Targets Inflamm. Allergy, 2002, 1, 257.
10. Hosoi, T.; Okuma, Y.; Nomura, Y. Am. J. Physiol. Regulatory Integrative Comp. Physiol., 2000, 279, R141.
11. Nathanson, J.A.; Chun, L.L.Y. Proc. Natl. Acad. Sci. USA, 1989, 86, 1684.
12. Kim, K.S.; Wass, C.A.; Cross, A.S. Exp. Neurol., 1997, 145, 253.
13. Devries, H.E.; Kuiper, J.; Deboer, A.G.; Van Berkel, T.J.C.; Breimer, D.D. Pharmacol. Rev., 1997, 49, 143.
14. Banks, W.A.; Farr, S.A.; Morley, J.E. Neuroimmunomodulation, 2002-2003, 10, 319.
15. Ghali, R.P.; Herx, L.M.; Maa, A.; Levine, R.L. Brain Res., 2000, 854, 178.
16. Gazda, L.S.; Milligan, E.D.; Hansen, M.K.; Twining, C.M.; Poulos, N.M.; Chacur, M.; O'Connor, K.A.; Armstrong, C.; Maier, S.F.; Watkins, L.R.; Myers, R.R. J. Peripher. Nerv. Syst., 2001, 6, 111.
17. Wang, X.; Feuerstein, G.Z. Drug News Perspect., 2000, 13, 133.
18. Szelenyi, J. Brain Res. Bull., 2001, 54, 329.
19. Blalock, J.E. J. Exp. Med., 2002, 195, F25.
20. Turnbull, A.V., Rivier, C.L. Physiol. Rev., 1999, 79, 1.
21. Toulmond, A.V., Pamet, P., Linthorst, A.C.E. TINS, 1996, 19, 409.
22. Reyes, T.M., Coe, C.L. Am. J. Physiol., 1998, 274, R139.
23. Genton, L.; Kudsk, K.A. Am. J. Surg., 2003, 186, 253.
24. Vitkovic, L.; Bockaert, J.; Jacque, C. J. Neurochem., 2000, 74, 457.
25. Liberto, C.M.; Albrecht, P.J.; Herx, L.M.; Yong, V.W.; Levison, S.W. J. Neurochem., 2004, 89, 1092.
26. Dantzer, R.; Bluthe, R.M.; Laye, S.; Bret-Dibat, J.L.; Parnet, P.; Kelley, K.W. Ann. NY Acad. Sci., 1998, 840, 586.
27. Konsman, J.P.; Parnet, P.; Dantzer, R. Trends Neurosci., 2002, 25, 154.
28. Kelley, K.W.; Bluthe, R.M.; Dantzer, R.; Zhou, J.H.; Shen, W.H.; Johnson, R.W.; Broussard, S.R. Brain Behav. Immun., 2003, 17, S112.
29. Dantzer, R. Ann. N. Y. Acad. Sci., 2001, 933, 222.
30. Dantzer, R.; Wollman, E.E.; Vitkovic, L.; Yirmiya, R. Adv. Exp. Med. Biol., 1999, 461, 317.
31. Dardenne, M.; Safieh-Garabedian, B.; Pleau, J.M. In Pain and Neuroimmune Interactions, Saadé, N.E.; Apkarian, A.V.; Jabbur, S.J., Eds.; Kluwer Academic/Plenum Publisher: New York, 2000; p. 127.
32. Saadé, N.E.; Baliki, M.; El-Khoury, C.; Hawwa, N.; Atweh, S.F.; Apkarian, A.V.; Jabbur, S.J. Neuroscience, 2002a, 115, 403.
33. Saadé, N.E.; Massaad, C.A.; Ochoa-Chaar, C.I.; Jabbur, S.J.; Safieh-Garabedian, B.; Atweh, S.F. J. Physiol., 2002b, 545, 241.
34. Dantzer, R. Mol. Psychiatry, 1997, 2, 83.
35. Haddad, J.J. Biochem. Biophys. Res. Commun., 2002a, 297, 700.
36. Relton, J.K.; Strijbos, P.J.; O'Shaughnessy, C.T.; Carey, F.; Forder, R.A.; Tilders, F.J.; Rothwell, N.J. J. Exp. Med., 1991, 174, 305.
37. Watanabe, T.; Hiltz, M.E.; Catania, A.; Lipton, J.M. Brain Res. Bull., 1993, 32, 311.
38. Ceriani, G.; Macaluso, A.; Catania, A.; Lipton, J.M. Neuroendocrinology, 1994, 59, 138.
39. Asadullah, K.; Sterry, W.; Volk, H.D. Pharmacol. Rev., 2003, 55. 241.
40. Allan, S.M.; Rothwell, N.J. Nat. Rev. Neurosci., 2001, 2, 734.
41. Nguyen, M.D.; Julien, J-P.; Rivest, S. Nat. Rev. Neurosci., 2002, 3, 216.
42. Knoblach, S.M.; Faden, A.I. Exp. Neurol., 1998, 153, 143.
43. Brewer, K.L.; Bethea, J.R.; Yezierski, R.P. Exp. Neurol., 1999, 159, 484.
44. Froen, J.F.; Munkeby, B.H.; Stray-Pedersen, B.; Saugstad, O.D. Brain Res., 2002, 942, 87.
45. Poliani, P.L.; Brok, H.; Furlan, R.; Ruffini, F.; Bergami, A.; Desina, G.; Marconi, P.C.; Rovaris, M.; Uccelli, A.; Glorioso, J.C.; Penna, G.; Adorini, L.; Comi, G.; 't Hart, B.; Martino, G. Hum. Gene Ther., 2001, 12, 905.
46. Floris, S.; Ruuls, S.R.; Wierinckx, A.; van der Pol, S.M.; Dopp, E.; van der Meide, P.H.; Dijkstra, C.D.; De Vries, H.E. J. Neuroimmunol., 2002, 127, 69.
47. Eid, T.; Brines, M. Clin. Breast Cancer, 2002, 3, S109.
48. Gorio, A.; Gokmen, N.; Erbayraktar, S.; Yilmaz, O.; Madaschi, L.; Cichetti, C.; Di Giulio, A.M.; Vardar, E.; Cerami, A.; Brines, M. Proc. Natl. Acad. Sci. USA, 2002, 99, 9450.
49. Beech, J.S.; Reckless, J.; Mosedale, D.E.; Grainger, D.J.; Williams, S.C.; Menon, D.K. J. Cereb. Blood Flow Metab., 2001, 21, 683.
50. Munck, A.; Naray-Fejes-Toth, A. Ann. NY Acad. Sci., 1994, 746, 115.
51. Parnet, P.; Kelley, K.W.; Bluthe, R.M.; Dantzer, R. J. Neuroimmunol., 2002, 125, 5.
52. Dinkel, K.; Ogle, W.O.; Sapolsky, R.M. J. Neurovirol., 2002, 8, 513.
53. Dinkel, K.; MacPherson, A.; Sapolsky, R.M. J. Neurochem., 2003, 84, 705.
54. del Rey, A.; Klusman, I.; Besedovsky, H.O. Am. J. Physiol., 1998, 275, R1146.
55. Ma, T.C.; Zhu, X.Z. Arzneimittelforschung, 1997, 47, 595.
56. Flavin, M.P.; Ho, L.T.; Coughlin, K. Exp. Neurol., 1997, 145, 462.
57. Buttini, M.; Mir, A.; Appel, K.; Wiederhold, K.H.; Limonta, S.; Gebicke-Haerter, P.J.; Boddeke, H.W. Br. J. Pharmacol., 1997, 122, 1483.
58. Zhu, J.; Mix, E.; Winblad, B. CNS Drug Rev., 2001, 7, 387.
59. Davidson, J.; Abul, H.T.; Milton, A.S.; Rotondo, D. Pflugers Arch., 2001, 442, 526.
60. Greco, A.; Ajmone-Cat, M.A.; Nicolini, A.; Sciulli, M.G.; Minghetti, L. J. Neurosci. Res., 2003, 71, 844.
61. Bourke, E.; Moynagh, P.N. J. Immunol., 1999, 163, 2113.
62. Haddad, J.J.; Lauterbach, R.; Saadé, N.E.; Safieh-Garabedian, B.; Land, S.C. Biochem. J., 2001, 355, 29.
63. Fiebich, B.L.; Hofer, T.J.; Lieb, K.; Huell, M.; Butcher, R.D.; Schumann, G.; Schulze-Osthoff, K.; Bauer, J. Neuropharmacology, 1999, 38, 1325.
64. Haddad, J.J.; Olver, R.E.; Land, S.C. J. Biol. Chem., 2000b, 275, 21130.
65. Bour, A.M.; Westendorp, R.G.; Laterveer, J.C.; Bollen, E.L.; Remarque, E.J. Exp. Gerontol., 2000, 35, 1017.
66. Nicholson, T.E.; Renton, K.W. Drug Metab. Dispos., 2002, 30, 42.
67. De La Garza, R.; Asnis, G.M. Brain Res., 2003, 977, 70.
68. Ray, S.K.; Banik, N.L. Curr. Drug Target CNS Neurol. Disord., 2003, 2, 173.
69. Hisahara, S.; Araki, T.; Sugiyama, F.; Yagami, K.; Suzuki, M.; Abe, K.; Yamamura, K.; Miyazaki, J.; Momoi, T.; Saruta, T.; Bernard, C.C.; Okano, H.; Miura, M. EMBO J., 2000, 19, 341.
70. Lev, N.; Barhum, Y.; Melamed, E.; Offen, D. Neurosci. Lett., 2004, 359, 139.
71. Hisahara, S.; Okano, H.; Miura, M. Neurosci Res., 2003, 46, 387.
72. Sercarz, E.; Maverakis, E.; van den Elzen, P.; Madakamutil, L.; Kumar, V. Novartis Found Symp., 2003, 252, 165.
73. Lotocki, G.; Keane, R.W. IUBMB Life, 2002, 54, 231.
74. Perrelet, D.; Ferri, A.; Liston, P.; Muzzin, P.; Korneluk, R.G.; Kato, A.C. Nat. Cell Biol., 2002, 4, 175.
75. Haddad, J.J.; Saadé, N.E.; Safieh-Garabedian, B. Cell. Signal., 2003, 15, 255.
76. Yang, Y.; Sharma, A.; Sharma, R.; Patrick, B.; Singhal, S.S.; Zimniak, P.; Awasthi, S.; Awasthi, Y.C. J. Biol. Chem., 2003, 278, 41380.
77. Raghupathi, R.; Muir, J.K.; Fulp, C.T.; Pittman, R.N.; McIntosh, T.K. Exp. Neurol., 2003, 183, 438.
78. Nozaki, K.; Nishimura, M.; Hashimoto, N. Mol. Neurobiol., 2001, 23, 1.
79. Takai, H.; Katayama, K.; Yasoshima, A.; Uetsuka, K.; Nakayama, H.; Doi, K. Exp. Toxicol. Pathol., 2003, 55, 33.
80. Dray, A.; Urban, L. Annu. Rev. Pharmacol. Toxicol., 1996, 36, 253.
81. Saadé, N.E.; Atweh, S.F.; Jabbur, S.J.; Dardenne, M.; Bach, J.F.; Safieh-Garabedian, B. Neuroscience, 2003, 119, 155.
82. Lipton, S.A. Brain Pathol., 1996, 6, 507.
83. Hara, H.; Friedlander, R.M.; Gagliardini, V.; Ayata, C.; Fink, K.; Huang, Z.; Shimizu-Sasamata, M.; Yuan, J.; Moskowitz, M.A. Proc. Natl. Acad. Sci. USA, 1997, 94, 2007.
84. Bond, A.; Jones, N.M.; Hicks, C.A.; Whiffin, G.M.; Ward, M.A.; O'Neill, M.F.; Kingston, A.E.; Monn, J.A.; Ornstein, P.L.; Schoepp, D.D.; Lodge, D.; O'Neill, M.J. J. Pharmacol. Exp. Ther., 2000, 294, 800.
85. Thomas, A.G.; Liu, W.; Olkowski, J.L.; Tang, Z.; Lin, Q.; Lu, X.C.; Slusher, B.S. Eur. J. Pharmacol., 2001, 430, 33.
86. Ma, X.C.; Gottschall, P.E.; Chen, L.T.; Wiranowska, M.; Phelps, C.P. Neuroimmunomodulation, 2002-2003, 10, 199.
87. Haddad, J.J.; Land, S.C.; Saadé, N.E.; Safieh-Garabedian, B. Biochem. Biophys. Res. Commun., 2000a, 274, 500.
88. Haddad, J.J. Crit. Care, 2002c, 6, 481.
89. Raju, U.; Gumin, G.J.; Tofilon, P.J. Radiat. Oncol. Investig., 1999, 7, 145.
90. Ichiyama, T.; Sakai, T.; Catania, A.; Barsh, G.S.; Furukawa, S.; Lipton, J.M. J. Neuroimmunol., 1999, 99, 211.
91. Youdim, M.B.; Grunblatt, E.; Mandel, S. Ann. N. Y. Acad. Sci., 1999, 890, 7.
92. Li, Q.Q.; Bever, C.T. Brain Res. Mol. Brain Res., 2001, 87, 48.
93. Gao, F.; Bales, K.R.; Dodel, R.C.; Liu, J.; Chen, X.; Hample, H.; Farlow, M.R.; Paul, S.M.; Du, Y. Brain Res. Mol. Brain Res., 2002, 105, 108.
94. Chiarugi, A.; Moskowitz, M.A. J. Neurochem., 2003, 85, 306.
95. Skaper, S.D. Curr. Drug Target CNS Neurol. Disord., 2003, 2, 279.
96. Haddad, J.J.; Land, S.C. FEBS Lett., 2001, 505, 269.
97. Haddad, J.J. Eur. Cytokine Netw., 2002b, 13, 250.
98. Haddad, J.J. Crit. Care, 2003, 7, 47.
99. Jones, N.M.; Bergeron, M. J. Cereb. Blood Flow Metab., 2001, 21, 1105.
100. Lukiw, W.J.; Ottlecz, A.; Lambrou, G.; Grueninger, M.; Finley, J.; Thompson, H.W.; Bazan, N.G. Invest. Ophthalmol. Vis. Sci., 2003, 44, 4163.
101. Licinio, J.; Frost, P. Braz. J. Med. Biol. Res., 2000, 33, 1141.
102. Kim, O.S.; Park, E.J.; Joe, E.H.; Jou, I. J. Biol. Chem., 2002, 277, 40594.
103. Dell'Albani, P.; Santangelo, R.; Torrisi, L.; Nicoletti, V.G.; Giuffrida Stella, A.M. Neurochem. Res., 2003, 28, 53.
104. Bright, J.J.; Natarajan, C.; Sriram, S.; Muthian, G. Glia, 2004, 45, 188.
105. Cannella, B.; Raine, C.S. Ann. Neurol., 2004, 55, 46.
106. Luger, T.A.; Scholzen, T.E.; Brzoska, T.; Bohm, M. Ann. NY Acad. Sci., 2003, 994, 133.
107. Ichiyama, T.; Sato, S.; Okada, K.; Catania, A.; Lipton, J.M. Ann. NY Acad. Sci., 2000, 917, 221.
108. Poole, S.; Bristow, A.F.; Lorenzetti, B.B.; Das, R.E.; Smith, T.W.; Ferreira, S.H. Br. J. Pharmacol., 1992, 106, 489.
109. Ferreira, S.H.; Lorenzetti, B.B.; Bristow, A.F.; Poole, S. Nature, 1988, 334, 698.
110. Cunha, J.M.; Cunha, F.Q.; Poole, S.; Ferreira, S.H. Br. J. Pharmacol., 2000, 130, 1418.
111. Skottner, A.; Post, C.; Ocklind, A.; Seifert, E.; Liutkevicius, E.; Meskys, R.; Pilinkiene, A.; Biziuleviciene, G.; Lundstedt, T. Ann. NY Acad. Sci.; 2003, 994, 84.
112. Prasad, A.S.; Meftah, S.; Abdallah, J.; Kaplan, J.; Brewer, G.J.; Bach, J.F.; Dardenne, M. J. Clin. Invest., 1988, 82, 1202.
113. Mocchegiani, E.; Provinciali, M.; Di Stefano, G.; Nobilini, A.; Caramia, G.; Santarelli, L.; Tibaldi, A.; Fabris, N. Clin. Immunol. Immunopathol., 1995, 75, 214.
114. Safieh-Garabedian, B.; Ahmed, K.; Khamashta, M.A.; Taub, N.A.; Hughes, G.R. Int. Arch. Allergy Immunol., 1993, 101, 126.
115. Safieh-Garabedian, B.; Kanaan, S.A.; Jalakhian, R.H.; Jabbur, S.J.; Saadé, N.E. Brain Behav. Immun., 1997b, 11, 185.
116. Safieh-Garabedian, B.; Kanaan, S.A.; Jalakhian, R.H.; Poole, S.; Jabbur, S.J.; Saadé, N.E. J. Neuroimmunol., 1997a, 73, 162.
117. Savino, W.; Arzt, E.; Dardenne, M. Neuroimmunomodulation, 1999, 6, 126.
118. Safieh-Garabedian, B.; Kanaan, S.A.: Jabbur, S.J.; Atweh, S.F.; Saadé, N.E. In Pain and Neuroimmune Interactions, Saadé, N.E.; Apkarian, A.V.; Jabbur, S.J., Eds.; Kluwer Academic/Plenum Publisher: New York, 2000; p. 139.
119. Safieh-Garabedian, B.; Poole, S.; Haddad, J.J.; Massaad, C.A.; Jabbur, S.J.; Saadé, N.E. Neuropharmacology, 2002a, 42, 864.
120. Kanaan, S.A.; Safieh-Garabedian, B.; Karam, M.; Khansa, H.; Jabbur, S.J.; Jurjus, A.R.; Saadé, N.E. Brain Behav. Immun., 2002, 16, 450.
121. Safieh-Garabedian, B.; Dardenne, M.; Pleau, J.M.; Saadé, N.E. Br. J. Pharmacol., 2002b, 136, 947.
122. Binder, G.K.; Griffin, D.E. Science, 2001, 293, 303.
123. Chesler, D.A.; Reiss, C.S. Cytokine Growth Factor Rev., 2002, 13, 441.
124. Rempel, J.D.; Murray, S.J.; Meisner, J.; Buchmeier, M.J. Virology, 2004, 318, 381.
125. Griffin, D.E. Nat. Rev. Immunol., 2003, 3, 493.
126. Chesler, D.A.; Dodard, C.; Lee, G.Y.; Levy, D.E.; Reiss, C.S. J. Neurovirol., 2004, 10, 57.
127. Rodriguez, M.; Zoecklein, L.J.; Howe, C.L.; Pavelko, K.D.; Gamez, J.D.; Nakane, S.; Papke, L.M. J. Virol., 2003, 77, 12252.
128. Komastu, T.; Ireland, D.D.; Reiss, C.S. Cytokine Growth Factor Rev., 1998, 9, 277.
129. Hodges, J.L.; Ireland, D.D.; Reiss, C.S. Viral. Immunol., 2001, 14, 181.
130. Trifilo, M.J.; Montalto-Morrison, C.; Stiles, L.N.; Hurst, K.R.; Hardison, J.L.; Manning, J.E.; Masters, P.S.; Lane, T.E. J. Virol., 2004, 78, 585.
131. Cheeran, M.C.; Hu, S.; Sheng, W.S.; Peterson, P.K.; Lokensgard, J.R. J. Virol., 2003, 77, 4502.
132. Pavelko, K.D.; Howe, C.L.; Drescher, K.M.; Gamez, J.D.; Johnson, A.J.; Wei, T.; Ransohoff, R.M.; Rodriguez. M. J. Neurosci., 2003, 23, 481.
133. Keogh, B.; Atkins, G.J.; Mills, K.H.; Sheahan, B.J. Neuropathol. Appl. Neurobiol., 2003, 29, 553.
134. Cordelier, P.; Calarota, S.A.; Pomerantz, R.J.; Xiaoshan, J.; Strayer, D.S. J. Interferon Cytokine Res., 2003, 23, 477.
135. Haddad, J.J. Int. Immunopharmacol., 2004a, 4, 475.
136. Haddad, J.J. Biochem. Biophys. Res. Commun., 2004b, 316, 969.